Company Profile
Centrala Farmaceutyczna CEFARM S.A. seated in Warsaw
Description of activity
Centrala Farmaceutyczna CEFARM S.A. is one of the largest distributors of pharmaceuticals operating on the Polish market. The firm controls approximately 5 per cent of the market which places it in the top 10 largest pharmaceutical distributors in Poland. The Company provides supplies to wholesale companies, pharmacies, hospitals, as well as conducts export activity. The strategy of the company envisages take-overs of selected local pharmaceutical wholesale operations and pharmacy chains. The Polish pharmaceutical market is going through a consolidation stage. Centrala Farmaceutyczna CEFARM S.A. intends to consolidate around it entities which, together, account for approximately 15 per cent of the market. Building a strong market position is to enable Centrala Farmaceutyczna CEFARM S.A. a merger with another entity or to continue acquisitions.
Contact information
Province : mazowieckie
Centrala Farmaceutyczna CEFARM
ul. Jana Kazimierza 16
01-248 Warsaw
switchboard ph.: (+48 22) 634 02 22
fax: (+48 22) 634 03 59
Secretary Office of the Management Board
ph.: (+48 22) 634 01 50
fax: (+48 22) 634 01 53
www.cefarm.com.pl
Ministry of Treasury
ul. Krucza 36 / Wspólna 6
00-522 Warszawa
Department of Privatisation
ph.: (+48 22) 695 87 22, 695 87 05
fax: (+48 22) 695 88 18
Investor Realtions Centre
ph.: (+48 22) 695 90 01
ph.: (+48 22) 695 90 02
fax: (+48 22) 629 98 38
investor@msp.gov.pl
www.msp.gov.pl
Branch
Pharmaceutical
Performance in thousand PLN
|
|
2008
|
2009
|
2010
|
|
Sales revenue
|
710 021.0
|
914 091.3
|
1 014 661.7
|
|
EBITDA
|
8 339.0
|
12 897.2
|
11 133.5
|
|
Net result
|
5 587.0
|
8 386.3
|
8 520.9
|
Planned privatisation
On 13 October 2011 Ministry of Treasury and PCZ S.A. seated in Wrocław signed a sales agreement regarding 85% of the company’s shares held by the Treasury. The value of transaction amounts to PLN 80 053 000,00.
History of privatisation process:
Signing a draft agreement: 1 September 2011
Negotiations exclusivity: 3 August 2011
Parellel negotiations: 21 June 2011
Extending the negotiations exclusivity: 31 May 2011
Negotiations exclusivity. 28 April 2011 - 3 June 2011
Binding offers: 28.02.2011
Companies allowed to carry out a due diligence: 22 February 2011
Initial offers: 13 December 2010
Invitation to participate in negotiations: 8 November 2010
Withdrawal from negotiations: 7 July 2010
Negotiations: 28 January 2010
Binding offers: 15 January 2010
Due dilligence: 17 November 2009
Initial offers: 23 September 2009
Invitation to participate in negotiations: 11 August 2009
Employment
338 employees
Initial capital
PLN 55 000 000.00
President of the Management Board
Piotr Latwiec
Privatisation advisor
F5 Konsulting Sp. z o.o. with registered office in Poznań
Modification date : 29.03.2012